Ricardo Hitt

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

Jan B. Vermorken, Fernando Rivera, Éva Remenár et al. · New England Journal of Medicine · 2008 · 3.7K citations · Full text

Medicine, Oncology, Pharmacology +16

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy

Jan B. Vermorken, José Trigo, Ricardo Hitt et al. · Journal of Clinical Oncology · 2007 · 1K citations · Full text

Medicine, Oncology, Pharmacology +16

Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

José Baselga, José Trigo, Jean Bourhis et al. · Journal of Clinical Oncology · 2005 · 491 citations

Medicine, Oncology, Chemotherapy +13

Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer

Ricardo Hitt, Antonio López–Pousa, Javier Martínez‐Trufero et al. · Journal of Clinical Oncology · 2005 · 454 citations

Medicine, Oncology, Radiation Oncology +15

A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer

Ricardo Hitt, Juan J. Grau, Antonio López–Pousa et al. · Annals of Oncology · 2013 · 352 citations

Medicine, Oncology, Radiation Oncology +11